Literature DB >> 31598606

Are These Truly Rheumatoid Arthritis or Antisynthetase Syndrome Cases?

Sertaç Ketenci1, Ender Salbaş2.   

Abstract

Entities:  

Year:  2018        PMID： 31598606      PMCID： PMC6768775          DOI： 10.5606/ArchRheumatol.2019.6978

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN： 2148-5046            Impact factor:   1.472


× No keyword cloud information.
  10 in total

1.  The antisynthetase syndrome.

Authors:  Harsh C Patel; Naudia N Lauder
Journal:  Am J Med       Date:  2011-05-27       Impact factor: 4.965

Review 2.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

Review 3.  Antisynthetase syndrome.

Authors:  Elena Katzap; Maria-Louise Barilla-LaBarca; Galina Marder
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

4.  Antisynthetase syndrome presenting as rheumatoid-like polyarthritis.

Authors:  Gregory E Mumm; Kevin M McKown; Carolyn L Bell
Journal:  J Clin Rheumatol       Date:  2010-10       Impact factor: 3.517

5.  Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria.

Authors:  Karin Britsemmer; Jennie Ursum; Martijn Gerritsen; L H van Tuyl; Lilian van Tuyl; Dirkjan van Schaardenburg
Journal:  Ann Rheum Dis       Date:  2011-05-17       Impact factor: 19.103

6.  Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.

Authors:  Ana C Zamora; Sumedh S Hoskote; Beatriz Abascal-Bolado; Darin White; Christian W Cox; Jay H Ryu; Teng Moua
Journal:  Respir Med       Date:  2016-07-16       Impact factor: 3.415

7.  A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

Authors:  M Dastmalchi; C Grundtman; H Alexanderson; C P Mavragani; H Einarsdottir; S Barbasso Helmers; K Elvin; M K Crow; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2008-02-13       Impact factor: 19.103

8.  Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial.

Authors:  Anna Tjärnlund; Quan Tang; Cecilia Wick; Maryam Dastmalchi; Herman Mann; Jana Tomasová Studýnková; Radka Chura; Nicola J Gullick; Rosaria Salerno; Johan Rönnelid; Helene Alexanderson; Eva Lindroos; Rohit Aggarwal; Patrick Gordon; Jiri Vencovsky; Ingrid E Lundberg
Journal:  Ann Rheum Dis       Date:  2017-10-09       Impact factor: 19.103

9.  The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease.

Authors:  Masakazu Matsushita; Naoto Tamura; Michihiro Ogasawara; Kurisu Tada; Ken Yamaji; Yoshinari Takasaki
Journal:  Arch Rheumatol       Date:  2017-10-12       Impact factor: 1.472

10.  Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care.

Authors:  Lauren Kennish; Monalyn Labitigan; Sam Budoff; Maria T Filopoulos; W Andrew McCracken; Christopher J Swearingen; Yusuf Yazici
Journal:  BMJ Open       Date:  2012-10-03       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.